I wouldn't mind a buyout if the price was high enough. The potential is so huge that they shouldn't sell for less than $100/share which would be about $5B since there's around 50M shares outstanding (including warrants). Of course, $5B would be chump change for Abbott Labs or DEXCOM.
Ron Ericson sounded pretty focused on the future of KNWN at LD Micro last week so, if there is a buyout, I give him kudos for a great acting job. But I guess KNWN is pretty much a development shop right now and they would need a different set of skills to manage a biomed device business so it makes sense to handoff the marketing/manufacturing headaches to an established company.
News 
Market Data 
Discover 
